Understanding THC: why preparation, route and other medicines matter

6 hours ago

5 min read

Understanding THC: editorial illustration showing preparation, absorption and interactions as influencing factors.

Author: Dipl.-Chem. Mohammad Reza Talebnasab · Editorial review: 13 October 2026

A laboratory report lists a THC value, a study examines a cannabis extract and a medicine contains dronabinol. Does that automatically mean the same effect? No. Chemically, delta-9-tetrahydrocannabinol remains the same molecule. Its effect cannot, however, be predicted from its name or a percentage alone. The preparation, route of administration, metabolism and other medicines change the context.

To understand THC’s effects, ask more precise questions: what was studied, how did it enter the body and what was it combined with? These questions help put studies and product information into context. They are not instructions for self-treatment.

Quick navigation: Concentration · Route of administration · Metabolism · Preparations · Interactions · CBD and THC · Driving · Questions to ask

A THC percentage tells only part of the story

A percentage initially describes a concentration. On its own, it tells you neither how much was actually absorbed nor how much reached the bloodstream. The terms used on the laboratory report matter too: THC, THCA and a calculated total THC value are not simply interchangeable.

THCA is the acidic precursor of THC. During decarboxylation, carbon dioxide is released and THC forms. Analytical experiments show that heat promotes this conversion. It must therefore be clear whether an analysis measures THC already present or also considers the conversion potential of the acidic precursor. This is a question of chemical identification, not evidence of a health effect. Wang et al., 2016: study of decarboxylation.

Why the route of administration makes a difference

The same quantity of a substance does not necessarily produce the same time course. In a comparative human study by Ohlsson and colleagues, THC blood concentrations rose more slowly and less consistently after oral administration than after inhalation. Observed effects also began later and lasted longer. The study involved eleven healthy people: it demonstrates a basic difference but does not provide universal timings for today’s preparations. Ohlsson et al., 1980.

Above all, this limits comparisons: findings for one route of administration cannot simply be transferred to another. Personal experiences are no substitute for a comparable study either. A delayed or differently perceived effect is not a reliable indication of less strain on the body.

11-OH-THC: metabolism does not immediately mean inactivation

THC undergoes chemical changes in the body. These produce, among other compounds, 11-hydroxy-THC, or 11-OH-THC. This substance is itself pharmacologically active. An early human study involving nine people found effects including intoxication and an increased heart rate after direct experimental administration. It demonstrates the metabolite’s activity, not a fixed everyday conversion rule between THC and 11-OH-THC. Lemberger et al., 1973.

THCA and 11-OH-THC have different roles: THCA is a plant precursor, whereas 11-OH-THC forms during human metabolism. Confusing them mixes up plant chemistry with processes inside the body.

Why a medicinal study does not describe every extract

‘Contains THC’ is not a sufficiently precise description of a medical treatment. A medicine has a defined composition and a specific indication. An extract may contain other components; a study of a THC/CBD combination therefore does not automatically answer questions about THC alone.

Nabiximols provides an example: Novotna and colleagues tested a THC/CBD preparation for MS-related spasticity. Of 572 people initially enrolled, 241 entered the randomised comparison phase. Participants had first been selected on the basis of a predefined symptom improvement after four weeks of treatment. The result is therefore particularly informative for this selected group. It does not describe all people with MS or arbitrary cannabis extracts. Novotna et al., 2011.

The German Sativex prescribing information also limits use to certain adults with MS-related spasticity and lists contraindications and adverse effects. Such a result is not a promise of effectiveness for online-shop products. German Sativex prescribing information.

Interactions work in both directions

Medicines can change how THC is processed. In a study of 36 healthy men, ketoconazole increased exposure following a THC/CBD spray, while rifampicin reduced it. Here, exposure means the measured amount of active substance in the body over time. Certain enzyme inhibitors can slow metabolism, while enzyme inducers can accelerate it. A specific combination was examined under controlled conditions. Stott et al., 2013.

Conversely, saying ‘THC always blocks the breakdown of other medicines’ is too broad. In a study of 18 healthy adults, the THC extract without CBD did not measurably inhibit the five CYP systems studied under the single-dose conditions tested. The CBD/THC combination, however, affected several of these enzyme systems. Such a finding is neither a general assurance of safety nor transferable to every formulation. Bansal et al., 2023.

Effects can also add up without involving an enzyme: alcohol and medicines that depress the central nervous system can increase drowsiness and coordination problems. A medical or pharmaceutical assessment therefore needs to consider all medicines, including over-the-counter products. Do not change prescribed medicines on your own. Sativex prescribing information: interactions.

CBD is not a reliable antidote to THC

The widespread idea that CBD generally offsets unwanted THC effects is not supported. Another analysis of the same controlled study involving 18 adults found that an orally administered CBD-rich THC preparation produced higher THC blood concentrations and greater unwanted and impairing effects than a preparation containing the same amount of THC without CBD. The experimental conditions also included the same test-drug cocktail. Zamarripa et al., 2023.

This does not mean that every THC/CBD combination has the same consequences. It shows why the ingredient ratio and study conditions form part of the finding. ‘With CBD’ is not, by itself, an assurance of safety.

Simple rules of thumb do not establish fitness to drive

In a randomised study of 26 adults who used cannabis occasionally, both THC-containing and THC/CBD-containing cannabis impaired lane keeping during the early measurement period. CBD did not prevent this impairment under the conditions studied. A later measurement without a statistically detectable difference does not provide general permission to drive. Arkell et al., 2020.

Neither a THC percentage nor feeling sober is sufficient evidence of safety. Particularly during prescribed treatment, fitness-to-drive questions require individual assessment; this article cannot establish a universal waiting period.

Three questions for your next conversation with a doctor or pharmacist

Which exact preparation is involved? Composition and dosage form are more informative than the general term ‘cannabis’.
Which other medicines and existing conditions are relevant? Consider more than prescription medicines alone.
What does the cited study actually demonstrate? The participant population, comparison treatment and measured outcome all matter.

The key point is that the THC molecule does not change its identity; the context changes. Recognising these differences helps you assess information without turning laboratory values or individual studies into a basis for self-treatment.

Our knowledge page What is delta-9-tetrahydrocannabinol? explores the chemical fundamentals and research evidence in more detail. The article Cannabinoids and medicines: interactions explains the general mechanisms.

Note: This article provides general scientific information and does not replace individual medical advice. It contains no dosing or consumption instructions. The cited studies did not examine Parmorcan® shop products.

Sources and further evidence

These sources are linked in the text above. The short descriptions provide orientation; original titles and bibliographic details are available in the linked publication.